SHOCKING: Executives - What They Never Told You

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT. Mark Singleton, Bioventus’ senior vice president and chief financi

MarketBeat · Jun 8

Celsius Plots Energy Drink Comeback as Alani, Rockstar Deals Reshape Growth

Celsius (NASDAQ:CELH) executives said the company is working through a major portfolio transition as it integrates Alani and Rockstar into its platform while repositioning the core Celsius brand for renewed growth. Speaking at an investor conference, Chairman and CEO John Fieldly described the comp

MarketBeat · Jun 7

Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial

Altimmune (NASDAQ:ALT) executives said the company is preparing to begin enrolling patients in the second half of the year for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, while also awaiting data from related alcohol-associated liver disease programs.

MarketBeat · Jun 5

Modine Manufacturing Q4 Earnings Call Highlights

Modine Manufacturing (NYSE:MOD) executives said the company closed fiscal 2026 with another record year for revenue and adjusted EBITDA, driven by rapid growth in data center cooling and the continuing reshaping of its portfolio toward higher-growth businesses. President and Chief Executive Officer

MarketBeat · May 27

Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus

Karyopharm Therapeutics (NASDAQ:KPTI) executives said the company expects to provide a fuller presentation of its Phase 3 SENTRY trial data for selinexor in myelofibrosis at the upcoming ASCO conference, while also outlining expected regulatory engagement and other development priorities during a re

MarketBeat · May 26

Flexsteel Industries Sees Outsized Growth as Margins Rise, Buybacks Cut Share Count

Flexsteel Industries (NASDAQ:FLXS) executives outlined the furniture manufacturer’s growth strategy, margin outlook and capital allocation priorities during a company presentation, emphasizing recent share gains despite a weak industry backdrop. President and CEO Derek Schmidt said the company has

MarketBeat · May 23

Flex Pitches AI Data Center Spin-Off as Power and Cooling Growth Accelerates

Flex (NASDAQ:FLEX) executives used a J.P. Morgan fireside chat to outline the rationale for the company’s latest planned spin-off, describe the growth expectations for the business being separated and frame the remaining Flex as a large, diversified manufacturing and services platform. Revathi Adva

MarketBeat · May 23

Booz Allen Hamilton Q4 Earnings Call Highlights

Booz Allen Hamilton (NYSE:BAH) executives said the government technology contractor exited what Chief Executive Horacio Rozanski called its “most challenging year” as a public company with stronger profitability than expected, even as revenue declined because of weakness in its civil business. On t

MarketBeat · May 22

Lightspeed Commerce Q4 Earnings Call Highlights

Lightspeed Commerce (NYSE:LSPD) executives said the company’s fiscal fourth quarter capped a “pivotal” year in which its narrower focus on North American retail and European hospitality drove stronger growth, improved profitability and a more streamlined operating model following the divestiture of

MarketBeat · May 21

Walmart Q1 Earnings Call Highlights

Walmart (NASDAQ:WMT) executives said the retailer delivered stronger-than-expected first-quarter fiscal 2027 sales growth, driven by higher transactions, e-commerce momentum, marketplace gains and growth in advertising and membership revenue, while higher fuel costs weighed on operating income. CEO

MarketBeat · May 21